NCT06892496 Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
| NCT ID | NCT06892496 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Virginia Commonwealth University |
| Condition | Mucosal Erosion |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2025-03-07 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2025-03-07 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study has been initiated to evaluate the question, "What is the best way to protect the palate after a gum graft is removed?" The overall objective is to determine if there is a difference in PROMs of donor site healing using different palatal post-operative protection techniques.
Eligibility Criteria
Inclusion Criteria: * At least 18 years of age * Healthy or Mild controlled systemic diseases with no functional limitations (ASA I or ASA II) * Sites with 1 to 3 teeth or implants requiring soft-tissue grafting * Minimum palatal thickness of 2 mm * Willing to participate and sign an informed consent Exclusion Criteria: * Patients with systemic conditions that could impair wound healing (i.e. diabetes, immunosuppressive, chemotherapy, etc.) * Pregnant patients * Patients with bleeding disorders or taking anticoagulants * Smokers * Patients with a history of palatal graft harvesting
Contact & Investigator
Rafael Amorim Cavalcanti de Siqueira
PRINCIPAL INVESTIGATOR
Virginia Commonwealth University
Frequently Asked Questions
Who can join the NCT06892496 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mucosal Erosion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06892496 currently recruiting?
Yes, NCT06892496 is actively recruiting participants. Contact the research team at amorimcavalr@vcu.edu for enrollment information.
Where is the NCT06892496 trial being conducted?
This trial is being conducted at Richmond, United States.
Who is sponsoring the NCT06892496 clinical trial?
NCT06892496 is sponsored by Virginia Commonwealth University. The principal investigator is Rafael Amorim Cavalcanti de Siqueira at Virginia Commonwealth University. The trial plans to enroll 56 participants.